Provided by Tiger Trade Technology Pte. Ltd.

EVEREST MED

36.400
+1.1403.23%
Volume:2.39M
Turnover:85.90M
Market Cap:12.89B
PE:-9.91
High:36.480
Open:35.300
Low:35.280
Close:35.260
52wk High:77.550
52wk Low:31.700
Shares:354.00M
HK Float Shares:354.00M
Volume Ratio:0.83
T/O Rate:0.68%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-3.673
ROE:-23.04%
ROA:-9.09%
PB:2.90
PE(LYR):-9.91
PS:13.37

Loading ...

Everest Medicines (1952) Announces Continuing Connected Transactions, Proposed Connected-Person Award, and 2026 Share Scheme

Bulletin Express
·
Feb 03

Everest Medicines (Stock Code: 1952) Announces Virtual EGM Arrangement for 24 February 2026

Bulletin Express
·
Feb 03

Everest Medicines (1952) Announces Virtual EGM Agenda and Share Schemes

Bulletin Express
·
Feb 03

Everest Medicines gibt Termin für außerordentliche Hauptversammlung bekannt

Reuters
·
Feb 03

Everest Medicines Limited (1952) Announces Book Closure Period for Extraordinary General Meeting

Bulletin Express
·
Feb 02

Everest Medicines Signs Lease Agreement for New Premises

Reuters
·
Jan 26

Financial Insights | Precious Metals Maintain High Heat, Space Infrastructure Concept Erupts

Stock News
·
Jan 26

Potential to Prevent Tumor Recurrence and Metastasis: Multiple Domestic Companies Report Progress

Deep News
·
Jan 23

Revenues Not Telling The Story For Everest Medicines Limited (HKG:1952)

Simply Wall St.
·
Jan 22

mRNA Cancer Vaccine Data Exceeds Expectations; Everest MED (01952) Accelerates Domestic Personalized Cancer Vaccine Deployment

Stock News
·
Jan 21

Everest Medicines Limited (1952) Announces Delay in Despatch of Circular

Bulletin Express
·
Jan 16

Everest Medicines to Present Company Update at J.P. Morgan Healthcare Conference

Reuters
·
Jan 06

No Products Secured Billion-Dollar Orders, Qiang Jing's Wife Cashed Out Before Sinovant's IPO

Deep News
·
Jan 05

Hong Kong Stock Movement | EVEREST MED (01952) Rises Nearly 6% Intraday; Subsidiary Initiates Phase I Clinical Trial for EVM14 Injection Targeting Squamous Non-Small Cell Lung Cancer

Stock News
·
Jan 05

Everest Med Chairman Wu Yifang Purchases 30,000 Shares at HK$37.98 Each

Deep News
·
Jan 04

Board Chairman Wu Yifang Purchases Additional 30,000 Shares of Everest Medicines (01952) at HK$37.98 Per Share

Stock News
·
Jan 02

BRIEF-Everest Medicines Says Chairman Purchases 30,000 Shares For HK$1.139 Million

Reuters
·
Dec 31, 2025

EVEREST MED (01952) Chairman Wu Yifang Acquires Additional 30,000 Shares

Stock News
·
Dec 31, 2025

Everest Medicines - Chairman Purchases 30,000 Shares for HK$1.139 Mln

THOMSON REUTERS
·
Dec 31, 2025

Hong Kong Stock Announcement Highlights | Everest MED: Original Product Nefecon® Technology Protected by Valid Chinese Patent ZL200980127272.5

Stock News
·
Dec 30, 2025